Welcome to the
Centre for Minimally Invasive Surgery
The Centre's Surgical Specialties are Neuroendoscopy, Brain Tumours,Skull Base Surgery,
Paediatric Neurosurgery and Functional Surgery.
Cure For Life Foundation™

FAQ


Brain Tumours | Brain Cancer | Tumour Classification 1 | Tumour Classification 2| Tumour Diagnosis and Treatment | Tumour Cures | Need for Steroids | Need for Radiotherapy

Tumour Cures

Can Neurosurgery Cure Brain Tumours? Radical macroscopic removal of low grade gliomas in children can be curative. Also, most extra-axial tumours, such as meningiomas, craniopharyngiomas and pituitary adenomas can be cured if removed totally. This cannot be said for high grade tumours in children and adults. The feasibility of curative surgery for low grade gliomas in adults remains unknown.

Is there scientific evidence for the benefit of radical resection of primary brain tumours?

Low grade Gliomas:

Laws ER Jr. Resection of low-grade gliomas. J Neurosurg. 2001 Nov;95(5):p731-2.
"Clearly, the more cells at risk, the more likely a tumor is to undergo the series of genetic events that ultimately leads to a more aggressive or malignant glioma. (Therefore), based on what we currently believe, the strategy of recommending radical resection of gliomas of the brain is probably a sound one."

Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas:

Department of Neurological Surgery, Brain Tumor Research Center, University of California San Francisco, 505 Parnassus Ave, Room M-779, San Francisco, CA 94143-0112, USA. jsmith1enator@gmail.com


PURPOSE: The prognostic role of extent of resection (EOR) of low-grade gliomas (LGGs) is a major controversy. We designed a retrospective study to assess the influence of EOR on long-term outcomes of LGGs. PATIENTS AND METHODS: The study population (N = 216) included adults undergoing initial resection of hemispheric LGG. Region-of-interest analysis was performed to measure tumor volumes based on fluid-attenuated inversion-recovery (FLAIR) imaging. RESULTS: Median preoperative and postoperative tumor volumes and EOR were 36.6 cm(3) (range, 0.7 to 246.1 cm(3)), 3.7 cm(3) (range, 0 to 197.8 cm(3)) and 88.0% (range, 5% to 100%), respectively. There was no operative mortality. New postoperative deficits were noted in 36 patients (17%); however, all but four had complete recovery. There were 34 deaths (16%; median follow-up, 4.4 years). Progression and malignant progression were identified in 95 (44%) and 44 (20%) cases, respectively. Patients with at least 90% EOR had 5- and 8-year overall survival (OS) rates of 97% and 91%, respectively, whereas patients with less than 90% EOR had 5- and 8-year OS rates of 76% and 60%, respectively. After adjusting each measure of tumor burden for age, Karnofsky performance score (KPS), tumor location, and tumor subtype, OS was predicted by EOR (hazard ratio [HR] = 0.972; 95% CI, 0.960 to 0.983; P < .001), log preoperative tumor volume (HR = 4.442; 95% CI, 1.601 to 12.320; P = .004), and postoperative tumor volume (HR = 1.010; 95% CI, 1.001 to 1.019; P = .03), progression-free survival was predicted by log preoperative tumor volume (HR = 2.711; 95% CI, 1.590 to 4.623; P <or= .001) and postoperative tumor volume (HR = 1.007; 95% CI, 1.001 to 1.014; P = .035), and malignant progression-free survival was predicted by EOR (HR = 0.983; 95% CI, 0.972 to 0.995; P = .005) and log preoperative tumor volume (HR = 3.826; 95% CI, 1.632 to 8.969; P = .002).

CONCLUSION: Improved outcome among adult patients with hemispheric LGG is predicted by greater EOR.

Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas:

Department of Neurosurgery, The Johns Hopkins School of Medicine, and Neuro-oncology Surgical Outcomes Research Laboratory, Baltimore, Maryland 21231, USA.


OBJECTIVE: It remains unknown whether the extent of surgical resection affects survival or disease progression in patients with supratentorial low-grade gliomas. METHODS: We conducted a retrospective cohort study (n = 170) between 1996 and 2007 at a single institution to determine whether increasing extent of surgical resection was associated with improved progression-free survival (PFS) and overall survival (OS). Surgical resection of gliomas defined as gross total resection (GTR) (complete resection of the preoperative fluid-attenuated inversion recovery signal abnormality), near total resection (NTR) (<3-mm thin residual fluid-attenuated inversion recovery signal abnormality around the rim of the resection cavity only), or subtotal resection (STR) (residual nodular fluid-attenuated inversion recovery signal abnormality) based on magnetic resonance imaging performed less than 48 hours after surgery. Our main outcome measures were OS, PFS, and malignant degeneration-free survival (conversion to high-grade glioma). RESULTS: One hundred thirty-two primary and 38 revision resections were performed for low-grade astrocytomas (n = 93) or oligodendrogliomas (n = 77). GTR, NTR, and STR were achieved in 65 (38%), 39 (23%), and 66 (39%) cases, respectively. GTR versus STR was independently associated with increased OS (hazard ratio, 0.36; 95% confidence interval, 0.16-0.84; P = 0.017) and PFS (HR, 0.56; 95% confidence interval, 0.32-0.98; P = 0.043) and a trend of increased malignant degeneration-free survival (hazard ratio, 0.46; 95% confidence interval, 0.20-1.03; P = 0.060). NTR versus STR was not independently associated with improved OS, PFS, or malignant degeneration-free survival. Five-year OS after GTR, NTR, and STR was 95, 80, 70%, respectively, and 10-year OS was 76, 57, and 49%, respectively. After GTR, NTR, and STR, median time to tumor progression was 7.0, 4.0, and 3.5 years, respectively. Median time to malignant degeneration after GTR, NTR, and STR was 12.5, 5.8, and 7 years, respectively.

CONCLUSION: GTR was associated with a delay in tumor progression and malignant degeneration as well as improved OS independent of age, degree of disability, histological subtype, or revision versus primary resection. GTR should be safely attempted when not limited by eloquent cortex.

Malignant Gliomas:

Lacroix M. et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001 Aug;95(2):p190-8.
"Gross-total tumor resection is associated with longer survival in patients with GBM, especially when other predictive variables are favorable."

Nitta T, Sato K. Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 1995 Jun 1;75(11):p2727-31.
"The favorable prognosis of patients with malignant gliomas depends upon the total resection of these tumors."

Chandler KL et al. Long-term survival in patients with glioblastoma multiforme. Neurosurgery 1993 May;32(5):p716-20.
"Among patients with glioblastoma multiforme, long-term survival is most likely for those who have a long disease-free interval after the initial diagnosis and receive multimodal therapy, including aggressive tumor removal."

 

 
Copyright © 2002 + Trade Mark ™ 2002-2006 The Centre For Minimally Invasive Neurosurgery Pty Ltd. Sydney, Australia